Tempol effect on oxidative and mitochondrial markers in preclinical models for prostate cancer

CONCLUSION: Tempol can be considered a beneficial therapy for PCa treatment considering its antioxidant and low toxicity properties, however the PCa progression must be evaluated to get successful therapy.PMID:38623092 | PMC:PMC11015989 | DOI:10.1093/toxres/tfae056

Source: Cancer Control - April 16, 2024 Category: Cancer & Oncology Authors: Isabela Maria Urra Rossetto Felipe Rabelo Santos Heloina Mariano da Silva Elaine Minatel Mariana Mesquitta Marcos Jos é Salvador F ábio Montico Val éria Helena Alves Cagnon Source Type: research